Estropipate
Suppliers
Names
[ CAS No. ]:
7280-37-7
[ Name ]:
Estropipate
[Synonym ]:
hydrogène sulfate de (8R,9S,13S,14S)-13-méthyl-17-oxo-7,8,9,11,12,13,14,15,16,17-décahydro-6H-cyclopenta[a]phénanthrén-3-yle - pipérazine (1:1)
Estrone hydrogen sulfate compound with piperazine (1:1)
Ogen
ORTHO-EST
Piperazinestron-sulfat
Estropipate
Estra-1,3,5(10)-trien-17-one 3-sulphate compound with Piperazine (1:1)
(8R,9S,13S,14S)-13-Methyl-17-oxo-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-3-ylhydrogen-sulfat-piperazin(1:1)
Estra-1,3,5(10)-trien-17-one, 3-(sulfooxy)-, compd. with piperazine (1:1)
UNII-SVI38UY019
17-Oxoestra-1,3,5(10)-trien-3-yl hydrogen sulfate - piperazine (1:1)
Estrone sulfate piperazine
(8R,9S,13S,14S)-13-methyl-17-oxo-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-3-yl hydrogen sulfate - piperazine (1:1)
Sulestrex
piperazine oestrone sulphate
MFCD00867399
Harmogen
EINECS 230-696-3
Piperazine estrone sulfate
Chemical & Physical Properties
[ Molecular Formula ]:
C22H32N2O5S
[ Molecular Weight ]:
436.565
[ Exact Mass ]:
436.203186
[ PSA ]:
113.11000
[ LogP ]:
4.21100
[ Storage condition ]:
Store at RT
MSDS
Toxicological Information
CHEMICAL IDENTIFICATION
- RTECS NUMBER :
- KG7785000
- CAS REGISTRY NUMBER :
- 7280-37-7
- LAST UPDATED :
- 199506
- DATA ITEMS CITED :
- 1
- MOLECULAR FORMULA :
- C18-H22-O5-S.C4-H10-N2
- MOLECULAR WEIGHT :
- 436.62
Safety Information
[ Symbol ]:
GHS07, GHS08
[ Signal Word ]:
Danger
[ Hazard Statements ]:
H302-H350
[ Precautionary Statements ]:
P201-P280-P301 + P312 + P330-P308 + P313
[ Hazard Codes ]:
T
[ Risk Phrases ]:
45-22
[ Safety Phrases ]:
53-45
[ RIDADR ]:
NONH for all modes of transport
[ RTECS ]:
KG7785000
Articles
J. Exp. Med. 212 , 905-25, (2015)
Pentraxin 3 (PTX3) is a fluid-phase pattern recognition molecule and a key component of the humoral arm of innate immunity. In four different models of tissue damage in mice, PTX3 deficiency was assoc...
PLoS ONE 9(8) , e104952, (2014)
Snakebites are a serious public health problem due their high morbi-mortality. The main available specific treatment is the antivenom serum therapy, which has some disadvantages, such as poor neutrali...